ChemoCentryx, Inc.
(NASDAQ : CCXI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.50%183.671.3%$479.89m
ARRYArray BioPharma Inc.
0.23%46.618.1%$427.50m
CELGCelgene Corporation
0.35%98.171.3%$407.46m
GILDGilead Sciences, Inc.
0.31%68.470.9%$394.73m
BIIBBiogen Inc.
0.53%235.121.3%$352.53m
ILMNIllumina, Inc.
1.36%356.723.5%$286.04m
REGNRegeneron Pharmaceuticals, Inc.
2.95%320.002.6%$240.28m
VRTXVertex Pharmaceuticals Incorporated
0.63%182.901.9%$218.08m
AAgilent Technologies, Inc.
0.26%72.841.6%$195.74m
EXASExact Sciences Corporation
-0.60%115.3024.1%$188.03m
ALXNAlexion Pharmaceuticals, Inc.
3.54%128.162.0%$184.29m
BMRNBioMarin Pharmaceutical Inc.
1.25%86.094.3%$129.44m
SRPTSarepta Therapeutics, Inc.
-2.73%130.7414.7%$109.30m
INCYIncyte Corporation
1.89%86.472.5%$108.45m
MRTXMirati Therapeutics Inc.
3.21%104.482.5%$101.56m

Company Profile

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.